TokenPost·
Moderna Raises Full-Year Growth Outlook to 15% to 25% After Q3 Earnings Beat
Higher overseas COVID-19 vaccine sales drove revenue growth and helped produce the third-quarter earnings beat.
More news
- Crypto BriefingCisco unveils frontier AI red teaming and agent observability tools
- The BlockElizabeth Warren vows scrutiny of prediction markets, Trump family crypto ventures as Senate Banking chair
- Crypto BriefingTRON adds $16.1 billion to native stablecoin market cap in a year
- CryptoSlateXRP’s new euro cash-out route had less than €100 in its direct market
- crypto.newsCardano core teams near autonomy as IOG names latest partners
- NewsBTCSEC Staff Gives Canton Coin No-Action Relief, but the Conditions Matter